Purple Biotech GAAP EPS of -$0.09
Source: SeekingAlpha
2026-05-15 07:08:29 ET
More on Purple Biotech
- Purple Biotech Non-GAAP EPS of $19.85
- Seeking Alpha’s Quant Rating on Purple Biotech
- Historical earnings data for Purple Biotech
- Financial information for Purple Biotech
Read the full article on Seeking Alpha
For further details see:
Purple Biotech GAAP EPS of -$0.09
Purple Biotech Ltd.
NASDAQ: PPBT
PPBT Trading
0.35% G/L:
$2.89 Last:
5,198 Volume:
$2.92 Open:
PPBT Latest News
May 15, 2026 07:00:00 am
Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights
May 14, 2026 12:45:00 pm
First Patient Dosed in Phase 1 Trial Marks Expansion of NK Cell Engager Platform Into Solid Tumors
April 27, 2026 07:00:00 am
Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240
PPBT Stock Data
$1,562,570
2,425,222
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
IL
Rehovot
